Naturally fluorescent molecules may serve as cancer biomarker

April 2009
Diagnostics & Imaging Week;4/16/2009, Vol. 12 Issue 15, p1
The article reports that excess amounts of a naturally fluorescent molecule, nicotinamide adenine dinucleotide (NADH), might serve as a natural biomarker for cancer. According to researchers from Pennsylvania State University at University Park, the molecule could be the key to differentiating cancer cells from normal ones at the early stages of tumor progression. It fuels a series of biochemical reactions that involve various enzymes to produce adenosine triphosphate (ATP), the major energy source in cells.


Related Articles

  • Naturally Fluorescent Molecules May Serve as Cancer Biomarker. Pedersen, Amanda // BioWorld Today;4/20/2009, Vol. 20 Issue 74, p1 

    The article reveals that excess amounts of the fluorescent molecule could serve as a biomarker for cancer, according to researchers at Penn State University. Nicotinamide adenine dinucleotide (NADH) is a key coenzyme found in the inner membrane of a cell's power plant. Associate professor Ahmed...

  • P2X7 Mediates ATP-Driven Invasiveness in Prostate Cancer Cells. Qiu, Ying; Li, Wei-hua; Zhang, Hong-quan; Liu, Yan; Tian, Xin-Xia; Fang, Wei-Gang // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1 

    The ATP-gated P2X7 has been shown to play an important role in invasiveness and metastasis of some tumors. However, the possible links and underlying mechanisms between P2X7 and prostate cancer have not been elucidated. Here, we demonstrated that P2X7 was highly expressed in some prostate cancer...

  • Prostate cancer study reveals differential molecule.  // Medical Device Daily;3/23/2009, Vol. 13 Issue 54, p3 

    The article discusses a study from the National Cancer Institute's (NCI) Cancer Biomarkers Research Group which suggests that a molecule produced by the body's metabolism could be used to differentiate between benign prostate tissue versus localized and metastatic prostate cancer. The...

  • Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression. Santidrian, Antonio F.; Matsuno-Yagi, Akemi; Ritiand, Melissa; Seo, Byoung B.; LeBoeuf, Sarah E.; Gay, Laurie J.; Yagi, Takao; Felding-Habermann, Brunhilde // Journal of Clinical Investigation;Mar2013, Vol. 123 Issue 3, p1068 

    Despite advances in clinical therapy, metastasis remains the leading cause of death in breast cancer patients. Mutations in mitochondrial DNA, including those affecting complex I and oxidative phosphorylation, are found in breast tumors and could facilitate metastasis. This study identifies...

  • Multi-Target Analysis and Design of Mitochondrial Metabolism. Angione, Claudio; Costanza, Jole; Carapezza, Giovanni; Lió, Pietro; Nicosia, Giuseppe // PLoS ONE;9/16/2015, Vol. 10 Issue 9, p1 

    Analyzing and optimizing biological models is often identified as a research priority in biomedical engineering. An important feature of a model should be the ability to find the best condition in which an organism has to be grown in order to reach specific optimal output values chosen by the...

  • MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells. Jian Wu; Alin Ji; Xiao Wang; Yi Zhu; Yasai Yu; Yiwei Lin; Yunfu Liu; Shiqi Li; Zhen Liang; Xin Xu; Xiangyi Zheng; Liping Xie // Journal of Translational Medicine;9/6/2015, Vol. 13 Issue 1, p1 

    Background: An increasing number of studies have demonstrated that deregulation of microRNAs (miRNAs) was a common event in tumor tissues and miRNAs would be treated as ideal tumor biomarkers or therapeutic targets. miR-195-5p (termed as miR-195 for briefly in the following part) was suggested...

  • The Angiogenic Activity of Ascites in the Course of Ovarian Cancer as a Marker of Disease Progression. Gawrychowski, Krzysztof; Szewczyk, Grzegorz; Różewska, Ewa Skopińska; Malecki, Maciej; Barcz, Ewa; Kamiński, Paweł; Miedzińska-Maciejewska, Magdalena; Śmiertka, Wacław; Szukiewicz, Dariusz; Skopiński, Piotr // Disease Markers;2014, p1 

    Ovarian cancer cells are able to create invasive implants in the peritoneum and their growth is directly associated with the angiogenetic potential. This effect is probably stimulated by vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8), which are both found in ascites. The aim...

  • HCSD: the human cancer secretome database. Feizi, Amir; Banaei-Esfahani, Amir; Nielsen, Jens // Database: The Journal of Biological Databases & Curation;2015, Vol. 2015, p1 

    The human cancer secretome database (HCSD) is a comprehensive database for human cancer secretome data. The cancer secretome describes proteins secreted by cancer cells and structuring information about the cancer secretome will enable further analysis of how this is related with tumor biology....

  • Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer. Crea, Francesco; Hurt, Elaine M.; Mathews, Lesley A.; Cabarcas, Stephanie M.; Lei Sun; Marquez, Victor E.; Danesi, Romano; Farrar, William L. // Molecular Cancer;2011, Vol. 10 Issue 1, p40 

    Background: Polycomb repressive complex 2 (PRC2) mediates gene silencing through histone H3K27 methylation. PRC2 components are over-expressed in metastatic prostate cancer (PC), and are required for cancer stem cell (CSC) self-renewal. 3-Dezaneplanocin-A (DZNeP) is an inhibitor of PRC2 with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics